S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
The Lithium "Lie" (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
183 Pounds of Copper for Just ONE EV (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
183 Pounds of Copper for Just ONE EV (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
The Lithium "Lie" (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
183 Pounds of Copper for Just ONE EV (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
183 Pounds of Copper for Just ONE EV (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
The Lithium "Lie" (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
183 Pounds of Copper for Just ONE EV (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
183 Pounds of Copper for Just ONE EV (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
The Lithium "Lie" (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
183 Pounds of Copper for Just ONE EV (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
183 Pounds of Copper for Just ONE EV (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
NASDAQ:BEAT

BioTelemetry - BEAT Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$4.30
▼
$5.15
50-Day Range
$71.46
▼
$72.27
52-Week Range
$27.35
▼
$73.10
Volume
398,257 shs
Average Volume
380,374 shs
Market Capitalization
$35.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BEAT stock logo

About BioTelemetry (NASDAQ:BEAT) Stock

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Receive BEAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioTelemetry and its competitors with MarketBeat's FREE daily newsletter.

BEAT Stock News Headlines

November 16, 2022 | finance.yahoo.com
HeartBeam Snags New Patent For 12-Lead ECG Smartwatch-Based Monitor To Detect Heart Attacks
October 19, 2022 | finance.yahoo.com
Telemetry Global Market Report 2022 - Yahoo Finance
October 14, 2022 | finance.yahoo.com
Wearable Healthcare Devices Market Research Report by Product, Device Type, Therapeutic Devices, Grade, Channel, Application, End-Use Industry, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Yahoo Finance
October 13, 2022 | finance.yahoo.com
MHealth Solutions Market Set to Reach Valuation of USD 1,952.9 Billion with growing CAGR of 50.0% by 2029, Size, Share, Demand, Future Growth and Key Players Outlook - Yahoo Finance
October 13, 2022 | benzinga.com
HeartBeam to Present at LD Micro Main Event XV Conference - BioTelemetry (NASDAQ:BEAT) - Benzinga
October 12, 2022 | benzinga.com
How Is The Market Feeling About BioTelemetry? - BioTelemetry (NASDAQ:BEAT) - Benzinga
October 12, 2022 | benzinga.com
Digital Health Market is Projected to Reach US$ 561.52 Billion in 2028 - Benzinga
October 11, 2022 | finance.yahoo.com
Cardiac Output Monitoring Devices Market Size Worth ~USD 1.80 Billion by 2033 | CAGR: 4% – Research Nester - Yahoo Finance
October 11, 2022 | benzinga.com
CapitalGainsReport: Sector Spotlight Medical Monitoring Stocks. (BEAT, DXCM, WHSI, NMRD, GBS) - BioTeleme - Benzinga
October 8, 2022 | finance.yahoo.com
Patient Monitoring Devices Market worth $65.4 billion by 2027 – Exclusive Report by MarketsandMarkets™ - Yahoo Finance
October 3, 2022 | finance.yahoo.com
The Global Chronic Disease Management Market size is expected to reach $9.9 billion by 2028, rising at a market growth of 11.7% CAGR during the forecast period - Yahoo Finance
September 29, 2022 | benzinga.com
HeartBeam to Present at Upcoming Investor Conferences - BioTelemetry (NASDAQ:BEAT) - Benzinga
September 28, 2022 | nypost.com
Giants can’t succumb to overconfidence and expect to beat Cowboys
September 28, 2022 | finance.yahoo.com
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation
September 27, 2022 | benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Aridis Pharmaceuticals (NASDAQ:ARDS), Aque - Benzinga
September 26, 2022 | businesswire.com
Connected Health and Wellness Solutions Global Market Report 2022: Omron Healthcare, Koninklijke Philips, GE Healthcare, Dragerwerk, KGaA & Fitbit - ResearchAndMarkets.com - Business Wire
September 22, 2022 | businesswire.com
Worldwide Wearable Medical Devices Industry Report to 2031 - Players Include Xiaomi Technology, BioTelemetry, Fitbit, Garmin and Apple - ResearchAndMarkets.com - Business Wire
September 21, 2022 | streetinsider.com
Norwest Venture Partners Hires Zack Scott as General Partner on Healthcare Investment Team - StreetInsider.com
September 21, 2022 | benzinga.com
Wearable Healthcare Devices Market Size and Opportunities for New Players, Forecast from 2022 To 2028 by - Benzinga
September 15, 2022 | benzinga.com
Annovis Bio (NYSE:ANVS), BioTelemetry (NASDAQ:BEAT) – S&P 500 Down 0.6%; Crude Oil Falls Sharply - Benzinga
September 15, 2022 | benzinga.com
BioTelemetry (NASDAQ:BEAT) – Looking Into BioTelemetry's Recent Short Interest - Benzinga
September 15, 2022 | finance.yahoo.com
HeartBeam stock jumps amid heart monitor device patent
September 15, 2022 | benzinga.com
BioTelemetry (NASDAQ:BEAT) – Heartbeam shares are trading higher after the company announced its patent f - Benzinga
September 15, 2022 | benzinga.com
BioTelemetry (NASDAQ:BEAT), Armata Pharmaceuticals (AMEX:ARMP) – US Stocks Turn Lower; Nasdaq Drops Over - Benzinga
September 15, 2022 | benzinga.com
BioTelemetry (NASDAQ:BEAT) – HeartBeam Granted Patent For 12-Lead Electrocardiogram (ECG) Patch Monitor I - Benzinga
See More Headlines

Receive BEAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioTelemetry and its competitors with MarketBeat's FREE daily newsletter.

BEAT Company Calendar

Last Earnings
10/29/2020
Today
11/30/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/23/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BEAT
CUSIP
N/A
CIK
1574774
Web
www.gobio.com
Phone
610-729-7000
Fax
N/A
Employees
1,700
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,430,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-112.38%
Return on Assets
-105.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.16
Quick Ratio
7.16

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.72 per share
Price / Book
6.11

Miscellaneous

Outstanding Shares
8,000,000
Free Float
6,347,000
Market Cap
$35.20 million
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Joseph H. Capper (Age 57)
    CEO, Pres & Director
    Comp: $1.21M
  • Ms. Heather C. Getz (Age 46)
    Exec. VP, CFO & Chief Admin. Officer
    Comp: $616.68k
  • Mr. Fred Broadway III (Age 51)
    Pres of BioTel Heart
    Comp: $524.63k
  • Mr. Daniel M. Wisniewski (Age 57)
    Sr. VP of Technical Operations
    Comp: $506.54k
  • Dr. Andrei G. Stoica
    Chief Technology Officer
  • Cody Cowper
    VP of Legal & Corp. Sec.
  • Amy M. Knapp
    Vice president of Corp. Communications
  • Mr. Tim Raher
    Sr. VP of HR
  • Dr. Peter R. Kowey
    Medical Director and Chairman of Medical Advisory Board
  • Mr. Scott Satin
    Pres & GM of BioTel Research

Key Competitors

View All Competitors













BEAT Stock - Frequently Asked Questions

Should I buy or sell BioTelemetry stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioTelemetry in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BEAT shares.
View BEAT analyst ratings or view top-rated stocks.

When is BioTelemetry's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our BEAT earnings forecast.

How were BioTelemetry's earnings last quarter?

BioTelemetry, Inc. (NASDAQ:BEAT) released its quarterly earnings data on Thursday, October, 29th. The medical research company reported $0.45 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.07. The medical research company had revenue of $114.66 million for the quarter, compared to analysts' expectations of $105.12 million. The business's revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter last year, the business earned $0.52 EPS.

What is Joseph H. (Joe) Capper's approval rating as BioTelemetry's CEO?

40 employees have rated BioTelemetry Chief Executive Officer Joseph H. (Joe) Capper on Glassdoor.com. Joseph H. (Joe) Capper has an approval rating of 53% among the company's employees. This puts Joseph H. (Joe) Capper in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BioTelemetry own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioTelemetry investors own include NVIDIA (NVDA), Micron Technology (MU), Advanced Micro Devices (AMD), Block (SQ), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Netflix (NFLX) and Gilead Sciences (GILD).

When did BioTelemetry IPO?

(BEAT) raised $16 million in an initial public offering (IPO) on Thursday, November 11th 2021. The company issued 2,750,000 shares at $5.50-$6.50 per share.

What is BioTelemetry's stock symbol?

BioTelemetry trades on the NASDAQ under the ticker symbol "BEAT."

What is BioTelemetry's stock price today?

One share of BEAT stock can currently be purchased for approximately $4.40.

How much money does BioTelemetry make?

BioTelemetry (NASDAQ:BEAT) has a market capitalization of $35.20 million. The medical research company earns $-4,430,000.00 in net income (profit) each year or ($1.54) on an earnings per share basis.

How many employees does BioTelemetry have?

The company employs 1,700 workers across the globe.

How can I contact BioTelemetry?

BioTelemetry's mailing address is 1000 CEDAR HOLLOW ROAD, MALVERN PA, 19355. The official website for the company is www.gobio.com. The medical research company can be reached via phone at 610-729-7000 or via email at investorrelations@biotelinc.com.

This page (NASDAQ:BEAT) was last updated on 11/30/2022 by MarketBeat.com Staff